have substantiated this view by demonstrating the efficacy of both topical and oral melatonin in the treatment of melasma, when used as an adjunct with other topical therapies.[] They also demonstrated the safety of oral melatonin up to a dose of 3 mg/day given for 90 days, except for the occurrence of mild, transient drowsiness in some patients
Gallbladder problems Gallbladder problems are an uncommon but serious side effect reported with Mounjaro which may be linked to rapid weight loss during treatment
PubMed Hartman, M.L., Sanyal, A.J., Loomba, R., Wilson, J.M., Nikooienejad, A., Bray, R., et al
Its design gives it several distinct advantages over previous obesity drugs